We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Advisory Council on the Misuse of Drugs (ACMD) call for evidence on cannabinoids in CBD products.
Employment Tribunal decision.
We have a received a request under the Freedom of Information Act 2000 for the following: The definition for ‘special purposes and other special…
The importer and distributor of the above products has informed us of reports that the microbial limit for Total Microbial Aerobic Count (TAMC) has been tested to exceed the predefined limit of 200 CfU/g as per the product specification fixed...
The Medicines and Healthcare products Regulatory Agency has issued an opinion on the regulatory status of products containing CBD
Letter from Kit Malthouse MP to Professor Owen Bowden-Jones, Chair of the Advisory Council on the Misuse of Drugs (ACMD).
SIA response to a Freedom of Information (FOI) request for confirmation of whether SIA licence-linked training covers the possession of medical cannabis.
Number of licences granted for the cultivation of low and high tetrahydrocannabinol cannabis plants in England and Wales, 2010 to 2013.
The number of people charged with cultivation or production of cannabis.
Request for details of the background that led to David Blunkett's decision to downgrade cannabis from a class B drug to a class C drug.
The negative response to an FOI asking for CNC recorded offences of cannabis possession
The Medicines and Healthcare products Regulatory Agency has today issued a recall asking patients to return affected products.
CNC nil return response to an FOI about people charged with possession of cannabis
The VMD considers that veterinary products containing Cannabidiol are veterinary medicines.
Home Secretary to receive advice on cannabis-related medicinal products.
The ACMD has recommended that cannabis-derived medicinal products should be placed in Schedule 2 of the Misuse of Drugs Regulations 2001.
Specialist clinicians will be able to legally prescribe cannabis-derived medicinal products by the autumn, Home Secretary Sajid Javid announced today.
This circular draws attention to the contents of the Statutory Instrument (SI) – SI 2018/1055.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).